These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8978301

  • 1. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
    Pinyol M, Hernandez L, Cazorla M, Balbín M, Jares P, Fernandez PL, Montserrat E, Cardesa A, Lopez-Otín C, Campo E.
    Blood; 1997 Jan 01; 89(1):272-80. PubMed ID: 8978301
    [Abstract] [Full Text] [Related]

  • 2. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
    Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M.
    Blood; 1996 Apr 15; 87(8):3351-9. PubMed ID: 8605352
    [Abstract] [Full Text] [Related]

  • 3. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A.
    Am J Pathol; 1996 May 15; 148(5):1591-600. PubMed ID: 8623927
    [Abstract] [Full Text] [Related]

  • 4. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.
    Izban KF, Alkan S, Singleton TP, Hsi ED.
    Arch Pathol Lab Med; 2000 Oct 15; 124(10):1457-62. PubMed ID: 11035575
    [Abstract] [Full Text] [Related]

  • 5. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
    Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL, Montserrat E, Cardesa A, Campo E.
    Blood; 1998 Apr 15; 91(8):2977-84. PubMed ID: 9531609
    [Abstract] [Full Text] [Related]

  • 6. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 7. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
    Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VV, Schluger A, Chaganti RS.
    Blood; 1995 Oct 15; 86(8):2892-9. PubMed ID: 7579380
    [Abstract] [Full Text] [Related]

  • 8. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
    Chilosi M, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, Rahal D, Pedron S, Benedetti A, Scardoni M, Macrì E, Lestani M, Menestrina F, Pizzolo G, Scarpa A.
    Blood; 1996 Nov 15; 88(10):4012-20. PubMed ID: 8916968
    [Abstract] [Full Text] [Related]

  • 9. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T, Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1998 Nov 15; 18(3A):1537-42. PubMed ID: 9673367
    [Abstract] [Full Text] [Related]

  • 10. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes.
    Nagai M, Fujita M, Ohmori M, Matsubara S, Taniwaki M, Horiike S, Tasaka T, Koeffler HP, Takahara J.
    Hematol Oncol; 1997 Aug 15; 15(3):109-19. PubMed ID: 9600110
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
    Hangaishi A, Ogawa S, Imamura N, Miyawaki S, Miura Y, Uike N, Shimazaki C, Emi N, Takeyama K, Hirosawa S, Kamada N, Kobayashi Y, Takemoto Y, Kitani T, Toyama K, Ohtake S, Yazaki Y, Ueda R, Hirai H.
    Blood; 1996 Jun 15; 87(12):4949-58. PubMed ID: 8652807
    [Abstract] [Full Text] [Related]

  • 12. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
    Møller MB, Kania PW, Ino Y, Gerdes AM, Nielsen O, Louis DN, Skjødt K, Pedersen NT.
    Leukemia; 2000 May 15; 14(5):898-904. PubMed ID: 10803523
    [Abstract] [Full Text] [Related]

  • 13. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.
    Tort F, Hernàndez S, Beà S, Martínez A, Esteller M, Herman JG, Puig X, Camacho E, Sánchez M, Nayach I, Lopez-Guillermo A, Fernández PL, Colomer D, Hernàndez L, Campo E.
    Blood; 2002 Dec 15; 100(13):4602-8. PubMed ID: 12393693
    [Abstract] [Full Text] [Related]

  • 14. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).
    Jadayel DM, Lukas J, Nacheva E, Bartkova J, Stranks G, De Schouwer PJ, Lens D, Bartek J, Dyer MJ, Kruger AR, Catovsky D.
    Leukemia; 1997 Jan 15; 11(1):64-72. PubMed ID: 9001420
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia.
    Williams ME, Whitefield M, Swerdlow SH.
    Ann Oncol; 1997 Jan 15; 8 Suppl 2():71-3. PubMed ID: 9209645
    [Abstract] [Full Text] [Related]

  • 16. Bcl-1/cyclin D1 in malignant lymphoma.
    de Boer CJ, van Krieken JH, Schuuring E, Kluin PM.
    Ann Oncol; 1997 Jan 15; 8 Suppl 2():109-17. PubMed ID: 9209653
    [Abstract] [Full Text] [Related]

  • 17. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L, Davies-Hill T, Fend F, Calzada-Wack J, Sorbara L, Campo E, Jaffe ES, Raffeld M.
    Blood; 2003 Apr 15; 101(8):3181-7. PubMed ID: 12515730
    [Abstract] [Full Text] [Related]

  • 18. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma.
    Koduru PR, Zariwala M, Soni M, Gong JZ, Xiong Y, Broome JD.
    Blood; 1995 Oct 15; 86(8):2900-5. PubMed ID: 7579381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R, Pezzella F, Gatter K, Algara P, Sánchez-Beato M, Martínez P, Martínez JC, Muñoz K, García P, Sánchez L, Kocialkowsky S, Campo E, Orradre JL, Piris MA.
    J Pathol; 1997 Jan 15; 181(1):51-61. PubMed ID: 9072003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.